BP003220: Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer-Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer-Protein, (amino acids Gly25-Thr305(HLA-A*24:02) & Ile21-Met119(B2M)) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Human Peptide Ready HLA-A*24:02&B2M Monomer protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/well) on the streptavidin precoated plate (5 ug/ml). Dose response curve for the recombinant Anti-HLA class I (W6/32) Antibody protein with the C-hFc tag with the EC50 of 4.1 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003221: Human Peptide Ready HLA-A*24:02&B2M Monomer Protein with the C-His-Avi Tag
Source: The recombinant Human Peptide Ready HLA-A*24:02&B2M Monomer Protein, (amino acids Gly25-Thr305(HLA-A*24:02) & Ile21-Met119(B2M)) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human Peptide Ready HLA-A*24:02&B2M Monomer protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-HLA class I (W6/32) Antibody protein with the C-hFc tag with the EC50 of 3.1 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003292: Biotinylated Human Peptide Ready HLA-A*03:01&B2M Monomer Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human Peptide Ready HLA-A*03:01&B2M Monomer Protein, (amino acids Gly25-Thr305(HLA-A*03:01) & Ile21-Met119(B2M)) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Human Peptide Ready HLA-A*03:01&B2M Monomer protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the streptavidin precoated plate(5 ug/ml). Dose response curve for the recombinant Anti-HLA class I (W6/32) Antibody protein with the C-hFc tag with the EC50 of 4.2 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003106: PE-Labeled Human Peptide Ready HLA-A*03:01&B2M Tetramer Protein with the C-His-Avi Tag
Source: The recombinant PE-Labeled Human Peptide Ready HLA-A*03:01&B2M Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*03:01) & Ile21-Met119(B2M)) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant PE-Labeled Human Peptide Ready HLA-A*03:01&B2M Tetramer protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-HLA class I (W6/32) Antibody protein with the C-hFc tag with the EC50 of 6.0 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003336: PE-Labeled Human HLA-A*03:01&B2M&KRAS G12V (VVVGAVGVGK) Tetramer Protein with the C-His-Avi Tag
Source: The recombinant PE-Labeled Human HLA-A*03:01&B2M&KRAS G12V (VVVGAVGVGK) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*03:01), Ile21-Met119(B2M) and VVVGAVGVGK peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant PE-Labeled Human HLA-A*03:01&B2M&KRAS G12V (VVVGAVGVGK) Tetramer protein with the C-His-Avi tag at 5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-HLA-A*03:01&B2M&KRAS G12V (VVVGAVGVGK) Antibody protein with the C-hFc tag with the EC50 of 1.67 ug/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003099: PE-Labeled Human HLA-A*03:01&B2M&KRAS G12V (VVGAVGVGK) Tetramer Protein with the C-His-Avi Tag
Source: The recombinant PE-Labeled Human HLA-A*03:01&B2M&KRAS G12V (VVGAVGVGK) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*03:01), Ile21-Met119(B2M) and VVGAVGVGK peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003293: Human Peptide Ready HLA-A*03:01&B2M Monomer-Protein with the C-His-Avi Tag
Source: The recombinant Human Peptide Ready HLA-A*03:01&B2M Monomer-Protein, (amino acids Gly25-Thr305(HLA-A*03:01) & Ile21-Met119(B2M)) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human Peptide Ready HLA-A*03:01&B2M Monomer protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-HLA class I (W6/32) Antibody protein with the C-hFc tag with the EC50 of 5.1 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004021: Human HLA-A*24:02&B2M&Survivin 2B (AYACNTSTL) Tetramer Protein with the C-His-Avi Tag
Source: The recombinant Human HLA-A*24:02&B2M&Survivin 2B (AYACNTSTL) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*24:02), Ile21-Met119(B2M)and AYACNTSTL peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004022: Human HLA-A*24:02&B2M&Survivin 2B (AYACNTSTL) Monomer Protein with the C-His-Avi Tag
Source: The recombinant Human HLA-A*24:02&B2M&Survivin 2B (AYACNTSTL) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*24:02), Ile21-Met119(B2M)and AYACNTSTL peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003795: Human HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein with the C-His-Avi Tag
Source: The recombinant Human HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*24:02), Ile21-Met119(B2M)and IMPKAGLLI peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.